French real-life observational prospective study of hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women with advanced breast cancer treated with exemestane and everolimus
Latest Information Update: 11 Jan 2019
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms TANGO
Most Recent Events
- 11 Jan 2019 New trial record